These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 23751352
1. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J. Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352 [Abstract] [Full Text] [Related]
2. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M. Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911 [Abstract] [Full Text] [Related]
3. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J, Liu H, Wang H, Sun Y. Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [Abstract] [Full Text] [Related]
4. Clinical significance of microRNA-93 downregulation in human colon cancer. Xiao ZG, Deng ZS, Zhang YD, Zhang Y, Huang ZC. Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160 [Abstract] [Full Text] [Related]
5. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237 [Abstract] [Full Text] [Related]
6. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y. Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523 [Abstract] [Full Text] [Related]
7. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB, Hu JJ, Sun WJ, Duan XH, Chen X. Genet Mol Res; 2015 Dec 17; 14(4):17305-11. PubMed ID: 26681225 [Abstract] [Full Text] [Related]
8. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer. Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K, Endo F, Katagiri H, Ishida K, Kume K, Nishizuka S, Iinuma H, Wakabayashi G, Mori M, Sasako M, Mimori K. Clin Cancer Res; 2013 Dec 01; 19(23):6438-49. PubMed ID: 24097871 [Abstract] [Full Text] [Related]
9. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. Clin Cancer Res; 2011 May 01; 17(9):2725-33. PubMed ID: 21220473 [Abstract] [Full Text] [Related]
10. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL, Chen LM, Wang WM, Zhang LM. Diagn Pathol; 2015 Apr 29; 10():45. PubMed ID: 25924779 [Abstract] [Full Text] [Related]
11. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Luo M, Shen D, Wang W, Xian J. Int J Clin Exp Pathol; 2015 Apr 29; 8(5):5542-8. PubMed ID: 26191262 [Abstract] [Full Text] [Related]
12. Clinicopathologic significance of miR-10b expression in gastric carcinoma. Wang YY, Ye ZY, Zhao ZS, Li L, Wang YX, Tao HQ, Wang HJ, He XJ. Hum Pathol; 2013 Jul 29; 44(7):1278-85. PubMed ID: 23351547 [Abstract] [Full Text] [Related]
14. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, Ye F, Su Q, Xie X. Clin Cancer Res; 2013 Oct 15; 19(20):5602-12. PubMed ID: 23995857 [Abstract] [Full Text] [Related]
15. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T. J Clin Pathol; 2015 Oct 15; 68(10):795-801. PubMed ID: 26043748 [Abstract] [Full Text] [Related]
16. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study. Shi H, Han J, Yue S, Zhang T, Zhu W, Zhang D. Biomed Pharmacother; 2015 Apr 15; 71():210-5. PubMed ID: 25960238 [Abstract] [Full Text] [Related]
17. Identification of microRNA-205 as a potential prognostic indicator for human glioma. Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du F, Liu LJ, Liu YH, Liu XD, Jia JF, Li L, Wu ZL, Zhao G, Zhang ZG, Deng YC. J Clin Neurosci; 2013 Jul 15; 20(7):933-7. PubMed ID: 23683741 [Abstract] [Full Text] [Related]
18. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. J Surg Oncol; 2013 Apr 15; 107(5):505-10. PubMed ID: 22996433 [Abstract] [Full Text] [Related]
19. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer. Hu H, Li C, Cai S, Zhu C, Tian Y, Zheng J, Hu J, Chen C, Liu W. Hepatogastroenterology; 2014 Apr 15; 61(133):1478-82. PubMed ID: 25436328 [Abstract] [Full Text] [Related]
20. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y. Oncol Rep; 2012 Jan 15; 27(1):135-42. PubMed ID: 21947329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]